A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Denmark and Sweden, as Part of Local Clinical Practice (SURE DENMARK/SWEDEN)
SURE DENMARK/SWEDEN: A Multi-centre, Prospective, Non-interventional Study Investigating the Effectiveness of Once-weekly Subcutaneous Semaglutide in a Real World Adult Population With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Listed as NCT03648281, this observational or N/A phase trial focuses on Diabetes Mellitus, Type 2 and remains completed. Sponsored by Novo Nordisk A/S, it has been updated 24 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
24 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Oct 2021 — Dec 2021 [monthly]
Completed
▶ Show 19 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Active Not Recruiting
-
Jan 2020 — Feb 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Jan 2020 [monthly]
Active Not Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting
-
Sep 2019 — Oct 2019 [monthly]
Active Not Recruiting
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Enrolling By Invitation
-
May 2019 — Jun 2019 [monthly]
Enrolling By Invitation
-
Apr 2019 — May 2019 [monthly]
Enrolling By Invitation
-
Mar 2019 — Apr 2019 [monthly]
Enrolling By Invitation
-
Feb 2019 — Mar 2019 [monthly]
Enrolling By Invitation
-
Jan 2019 — Feb 2019 [monthly]
Enrolling By Invitation
-
Nov 2018 — Jan 2019 [monthly]
Enrolling By Invitation
-
Oct 2018 — Nov 2018 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
-
Sep 2018 — Oct 2018 [monthly]
Not Yet Recruiting
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novo Nordisk A/S
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Avesta, Sweden , Bjärred, Sweden , Bollnäs, Sweden , Charlottenberg, Sweden , Eslöv, Sweden , Falköping, Sweden , Flen, Sweden , Gothenburg, Sweden , Helsingborg, Sweden , Huskvarna, Sweden and 20 more locations